Robert Ecker
Internal Medicine · Columbus, OHNPI 1194701284
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,295 and has fallen 96.7% since, to $42 in 2025.
Across 112 payments — averaging $12.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$195
- AstraZeneca$154
- GSK$143
- Merck$123
- Johnson & Johnson$109
- Amgen$100
- plus $573 from 17 others
What the payments were for
- Food & beverage$1,38599%
- Education$111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $195 |
| AstraZeneca | 12 | $154 |
| GSK | 14 | $143 |
| Merck | 14 | $123 |
| Johnson & Johnson | 12 | $109 |
| Amgen | 5 | $100 |
| Amarin Pharma, Inc. | 4 | $71 |
| E.r. Squibb & Sons, L.L.C. | 5 | $66 |
| Astellas Pharma US Inc | 4 | $62 |
| Lilly USA, LLC | 4 | $51 |
| Boehringer Ingelheim | 3 | $45 |
| Imperative Care, Inc | 1 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Genentech USA, Inc. | 2 | $30 |
| Novartis | 2 | $28 |
| Antares Pharma, Inc. | 2 | $24 |
| Sanofi-aventis U.S. LLC | 2 | $23 |
| AbbVie | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Mission Pharmacal Company | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$1,397 in reported general payments places this provider in the 75th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Columbus
- Raghu KolluriColumbus$89K
- Youssef YoussefColumbus$59K
- Abdullah KhanColumbus$58K
- Benjamin BuckColumbus$35K
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.